Quentin and his team at CambridgeIP accelerate the development and deployment of valuable technologies for global leading clients including corporations, universities, investors and policy-makers. We provide our clients with global-leading access to data from patents and science literature, with analysis tools and with evidence-based insights drawn from our extensive technology and IP strategy experience. Quentin co-founded CambridgeIP and has lead the company from its outset. He has been instrumental in establishing CambridgeIP methods, databases and software tools. Quentin lead the acquisition of patent data portal Boliven.com for CambridgeIP, undertaking negotiations and managing due diligence and handover processes. Quentin has lead over 50 IP Landscape and IP strategy projects for CambridgeIP clients in the Energy, Health, Nanotechnology and Telecoms sectors. Quentin’s IP strategy and IP policy related work has been featured by Bloomberg, Nature Publishing Group, in the Wall Street Journal and elsewhere. He is a regular speaker at international IP and technology conferences. Quentin is a co-inventor on biomedical diagnostics patents.

CambridgeIP (Cambridge Intellectual Property Ltd) is a provider of technology intelligence and innovation strategy products and services to companies around the world. CambridgeIP's work has been covered in leading publications, including the Harvard Business Review, Wall Street Journal and Bloomberg. We have worked with some of the largest global companies, proving our systems and methods in over 120 major commercial projects. Our core focus areas are Health & Life Sciences, Energy & CleanTech, Telecommunications.
Examples of our products include: competitor mapping and analysis, technology mapping, technology market research, technology evaluation, industry-wide patent landscaping, patent expiry analysis, Boliven.com - a leading online information portal for the R&D community making available over 100 million scientific documents, and training to private and public organisations in high-technology sectors.

CambridgeIP’s rigorous methodology and supporting systems enable the gathering and analysis of highly complex science literature datasets with consistently superior quality and delivery times. Benefits are delivered with considerable efficiency when compared to traditional approaches.
CambridgeIP’s patent data coverage is excellent, achieved by merging patent office data with data from paid-for services to ensure maximum coverage. Working with high-quality datasets allows us to provide high-grade analytics (some of which are an industry-first) in support of strategic decision-making by our clients in the IP policy, IP strategy and R&D strategy fields, and in business strategy more broadly.

CambridgeIP is headquartered in Cambridge, UK, with offices in London, UK, and representatives in Boston, USA, Houston, USA, and Geneva, Switzerland. Our team has extensive experience in science and engineering disciplines, law and economics – enabling us effectively to interpret and communicate results of our research to the full spectrum of stakeholders in high-technology spaces.